RadNet, Inc. Income Tax Expense (Benefit), Continuing Operations, Discontinued Operations
RadNet, Inc. (RDNT) reported Income Tax Expense (Benefit), Continuing Operations, Discontinued Operations of $13.60 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-19.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems · last filed 2018-03-19
- RadNet, Inc. income tax expense (benefit), continuing operations, discontinued operations for fiscal 2017 was $13.60M.
| Period end | Income Tax Expense (Benefit), Continuing Operations, Discontinued Operations 12 month |
|---|---|
| 2017-12-31 | $13.60M 10-K · filed 2018-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |